IMMUNOPRECISE ANTIBODIES LTD's ticker is IPA and the CUSIP is 45257F200. A total of 27 filers reported holding IMMUNOPRECISE ANTIBODIES LTD in Q4 2021. The put-call ratio across all filers is 0.56 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $473 | -39.7% | 200 | 0.0% | 0.00% | – |
Q2 2023 | $785 | +16.6% | 200 | 0.0% | 0.00% | – |
Q1 2023 | $673 | -52.8% | 200 | 0.0% | 0.00% | – |
Q4 2022 | $1,425 | +16.4% | 200 | 0.0% | 0.00% | – |
Q3 2022 | $1,224 | +25.8% | 200 | 0.0% | 0.00% | – |
Q2 2022 | $973 | -25.3% | 200 | 0.0% | 0.00% | – |
Q1 2022 | $1,302 | -10.3% | 200 | 0.0% | 0.00% | – |
Q4 2021 | $1,452 | – | 200 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
INGALLS & SNYDER LLC | 932,200 | $4,792,000 | 0.21% |
Ikarian Capital, LLC | 77,650 | $399,000 | 0.05% |
Gradient Capital Advisors, LLC | 20,000 | $103,000 | 0.04% |
Belvedere Trading LLC | 37,100 | $209,000 | 0.01% |
WEST PACES ADVISORS INC. | 1,665 | $8,558 | 0.00% |
OSAIC HOLDINGS, INC. | 20 | $0 | 0.00% |
DIMENSIONAL FUND ADVISORS LP | 13,113 | $67,000 | 0.00% |
BANK OF AMERICA CORP /DE/ | 57,517 | $295,000 | 0.00% |
CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
GROUP ONE TRADING, L.P. | 3,466 | $18,000 | 0.00% |